featured
Dapagliflozin for the Treatment of Patients With Critical Illness and Acute Organ Dysfunction
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical Trial
JAMA 2024 Jun 14;[EPub Ahead of Print], CAM Tavares, LCP Azevedo, Á Rea-Neto, NS Campos, CP Amendola, AC Kozesinski-Nakatani, PG David-João, SM Lobo, TC Filiponi, GMB Almeida, RR Bergo, MRR Guimarães-Júnior, RC Figueiredo, JR Castro, CJ Schuler, GA Westphal, ACR Carioca, F Monfradini, J Nieri, FMO Neves, JA Paulo, CSN Albuquerque, MCR Silva, MN Kosiborod, AJ Pereira, LP Damiani, TD Corrêa, A Serpa-Neto, O Berwanger, FG ZampieriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.